The ubiquitous role of nitric oxide in cardioprotection

Journal of Molecular and Cellular Cardiology

Volumn 40, Issue 1, 2006, Pages 16-23

  Jones, Steven P ^a   Bolli, Roberto ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Infarct; Ischemia reperfusion; Mitochondria; Nitric oxide; Preconditioning

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

BIOAVAILABILITY; ELECTRON TRANSPORT; ENZYME ACTIVITY; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; MITOCHONDRIAL ENERGY TRANSFER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; REVIEW;

ANIMALS; HEART; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PROTECTIVE AGENTS;

EID: 29444432915     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2005.09.011     Document Type: Review

References (86)

1. T.L. Brunton On the use of nitrite of amyl in angina pectoris Lancet 2 1867 97
2. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells on the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
3. R.M.J. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526
4. L.J. Ignarro Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein Circ. Res. 65 1989 1 21
5. R. Bolli Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research J. Mol. Cell. Cardiol. 33 2001 1897 1918
6. P.L. Huang, Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, and J.A. Bevan Hypertension in mice lacking the gene for endothelial nitric oxide synthase Nature 377 1995 239 242
7. S.P. Jones, W.G. Girod, A.J. Palazzo, D.N. Granger, M.B. Grisham, and D. Jourd'Heuil Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase Am. J. Physiol. 276 1999 H1567 H1573
8. Y. Ohashi, S. Kawashima, K. Hirata, T. Yamashita, T. Ishida, and N. Inoue Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase J. Clin. Invest. 102 1998 2061 2071
9. R. van Haperen, M. de Waard, E. van Deel, B. Mees, M. Kutryk, and T. van Aken Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide J. Biol. Chem. 277 2002 48803 48807
10. S.P. Jones, J.J. Greer, A.K. Kakkar, P.D. Ware, R.H. Turnage, and M. Hicks Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury Am. J. Physiol. Heart Circ. Physiol. 286 2004 H276 H282
11. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
12. H. Post, R. Schulz, M. Behrends, P. Gres, C. Umschlag, and G. Heusch No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine J. Mol. Cell. Cardiol. 32 2000 725 733
13. A. Nakano, G.S. Liu, G. Heusch, J.M. Downey, and M.V. Cohen Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning J. Mol. Cell. Cardiol. 32 2000 1159 1167
14. Q. Qin, X.-M. Yang, L. Cui, S.D. Critz, M.V. Cohen, and N.C. Browner Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism Am. J. Physiol. Heart Circ. Physiol. 287 2004 H712 H718
15. R. Bolli The late phase of preconditioning Circ. Res. 87 2000 972 983
16. R. Bolli, B. Dawn, X.L. Tang, Y. Qiu, P. Ping, and Y.T. Xuan The nitric oxide hypothesis of late preconditioning Basic Res. Cardiol. 93 1998 325 338
17. Z.Q. Zhao, J.S. Corvera, M.E. Halkos, F. Kerendi, N.P. Wang, and R.A. Guyton Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am. J. Physiol. Heart Circ. Physiol. 285 2003 H579 H588
18. J. Vinten-Johansen, Z.Q. Zhao, A.J. Zatta, H. Kin, M.E. Halkos, and F. Kerendi Postconditioning-a new link in nature's armor against myocardial ischemia-reperfusion injury Basic Res. Cardiol. 100 2005 295 310
19. A. Tsang, D.J. Hausenloy, M.M. Mocanu, and D.M. Yellon Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway Circ. Res. 95 2004 230 232
20. X.M. Yang, S. Philipp, J.M. Downey, and M.V. Cohen Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation Basic Res. Cardiol. 100 2005 57 63
21. S.S.S. Group Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study Lancet 344 1994 1383 1389
22. J. Shepherd, S. Cobbe, I. Ford, C. Isles, A. Lorimer, and P. MacFarlane Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N. Engl. J. Med. 333 1995 1301 1307
23. U. Laufs, V.L. Fata, and J.K. Liao Inhibition of 3-hydroxy-3- methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase J. Biol. Chem. 272 1997 31725 31729
24. U. Laufs, V. La Fata, J. Plutzky, and J. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
25. O. Hernandez-Perera, D. Perez-Sala, J. Navarro-Antolin, R. Sanchez-Pascuala, G. Hernandez, and C. Diaz Effects of the 3-hydroxy-3- methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells J. Clin. Invest. 101 1998 2711 2719
26. A. Lefer, B. Campbell, Y.-K. Shin, R. Scalia, R. Hayward, and D. Lefer Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts Circulation 100 1999 178 184
27. S.P. Jones, M.F. Gibson, D.M. Rimmer 3rd, T.M. Gibson, B.R. Sharp, and D.J. Lefer Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor J. Am. Coll. Cardiol. 40 2002 1172 1178
28. R. Scalia, M.E. Gooszen, S.P. Jones, M. Hoffmeyer, D.M. Rimmer 3rd, and S.D. Trocha Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice Circulation 103 2001 2598 2603
29. S.P. Jones, S.D. Trocha, and D.J. Lefer Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion Arterioscler. Thromb. Vasc. Biol. 21 2001 2059 2064
30. D.J. Lefer, R. Scalia, S.P. Jones, B.R. Sharp, M.R. Hoffmeyer, and A.R. Farvid HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury FASEB J. 15 2001 1454 1456
31. S.P. Jones, Y. Teshima, M. Akao, and E. Marban Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes Circ. Res. 93 2003 697 699
32. M. Takemoto, K. Node, H. Nakagami, Y. Liao, M. Grimm, and Y. Takemoto Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy J. Clin. Invest. 108 2001 1429 1437
33. R.M. Bell, and D.M. Yellon Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway J. Am. Coll. Cardiol. 41 2003 508 515
34. R. Ockaili, F. Salloum, J. Hawkins, and R.C. Kukreja Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits Am. J. Physiol. Heart Circ. Physiol. 283 2002 H1263 H1269
35. F. Salloum, C. Yin, L. Xi, and R.C. Kukreja Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart Circ. Res. 92 2003 595 597
36. T. Reffelmann, and R.A. Kloner Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation Cardiovasc. Res. 59 2003 441 449
37. A. Das, R. Ockaili, F. Salloum, and R.C. Kukreja Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits Am. J. Physiol. Heart Circ. Physiol. 286 2004 H1455 H1460
38. Y.A. Bremer, F. Salloum, R. Ockaili, E. Chou, W.B. Moskowitz, and R.C. Kukreja Sildenafil citrate (viagra) induces cardioprotective effects after ischemia/reperfusion injury in infant rabbits Pediatr. Res. 57 2005 22 27
39. A. Das, L. Xi, and R.C. Kukreja Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling J. Biol. Chem. 280 2005 12944 12955
40. E. Takimoto, H.C. Champion, M. Li, D. Belardi, S. Ren, and E.R. Rodriguez Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy Nat. Med. 11 2005 214 222
41. P.W. Fisher, F. Salloum, A. Das, H. Hyder, and R.C. Kukreja Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity Circulation 111 2005 1601 1610
42. X.-P. Yang, Y.-H. Liu, E.G. Shesely, M. Bulagannawar, F. Liu, and O.A. Carretero Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury Hypertension 34 1999 24 30
43. B. Yang, D. Li, M.I. Phillips, P. Mehta, and J.L. Mehta Myocardial angiotensin II receptor expression and ischemia-reperfusion injury Vasc. Med. 3 1998 121 130
44. M. Hill, H. Takano, X.L. Tang, E. Kodani, G. Shirk, and R. Bolli Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance Circulation 104 2001 694 699
45. Q. Li, Y. Guo, Y.T. Xuan, C.J. Lowenstein, S.C. Stevenson, and S.D. Prabhu Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism Circ. Res. 92 2003 741 748
46. Q.H. Li, Y. Guo, W. Tan, S.C. Stevenson, C.J. Lowenstein, and W.J. Wu Long-term effects of gene therapy with inducible nitric oxide synthase on myocardial infarct size Circulation 108 2003 (IV-92)
47. R. Bolli, S. Manchikalapudi, X.L. Tang, H. Takano, Y. Qiu, and Y. Guo The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning Circ. Res. 81 1997 1094 1107
48. B.Y. Poon, E. Raharjo, K.D. Patel, S. Tavener, and P. Kubes Complexity of inducible nitric oxide synthase: cellular source determines benefit versus toxicity Circulation 108 2003 1107 1112
49. B. Zingarelli, P.W. Hake, Z. Yang, M. O'Connor, A. Denenberg, and H.R. Wong Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-{kappa}B and AP-1 activation and enhances myocardial damage FASEB J. 16 2002 327 342
50. Y.-P. Wang, H. Xu, K. Mizoguchi, M. Oe, and H. Maeta Intestinal ischemia induces late preconditioning against myocardial infarction: a role for inducible nitric oxide synthase Card. Res. 49 2001 391 398
51. K.M. Park, J.-Y. Byun, C. Kramers, J.I. Kim, P.L. Huang, and J.V. Bonventre Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney J. Biol. Chem. 278 2003 27256 27266
52. M.K. Jefayri, P.A. Grace, and R.T. Mathie Attenuation of reperfusion injury by renal ischaemic preconditioning: the role of nitric oxide BJU Int. 85 2000 1007 1013
53. S. Cho, E.-M. Park, P. Zhou, K. Frys, M.E. Ross, and C. Iadecola Obligatory role of inducible nitric oxide synthase in ischemic preconditioning J. Cereb. Blood Flow Metab. 25 2005 493 501
54. F. Jung, L.A. Palmer, N. Zhou, and R.A. Johns Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes Circ. Res. 86 2000 319 325
55. M. Kitakaze, K. Node, K. Komamura, T. Minamino, I. Inoue, and M. Hori Evidence for nitric oxide generation in the cardiomyocytes: its augmentation by hypoxia J. Mol. Cell. Card. 27 1995 2149 2154
56. G. Melillo, T. Musso, A. Sica, L.S. Taylor, G.W. Cox, and L. Vareiso A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter J. Exp. Med. 182 1995 1683 1693
57. C. Vargiu, S. Belliardo, C. Cravanzola, M.A. Grillo, and S. Colombatto Oxygen regulation of rat hepatocyte iNOS gene expression J. Hepatol. 32 2000 567 573
58. P. Liu, C.E. Hock, R. Nagele, and P.Y. Wong Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats Am. J. Physiol. Heart Circ. Physiol. 272 1997 H2327 H2336
59. S.M. Wildhirt, S. Weismueller, C. Schulze, N. Conrad, A. Kornberg, and B. Reichart Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury Cardiovasc. Res. 43 1999 698 711
60. J. Heger, A. Godecke, U. Flogel, M.W. Merx, A. Molojavyi, and W.N. Kuhn-Velten Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction Circ. Res. 90 2002 93 99
61. M.B. West, Y.-T. Xuan, G. Rokosh, Y. Guo, S. Prabhu, and R. Bolli Constitutive overexpression of inducible nitric oxide synthase protects the ischemic heart by inhibiting mitochondrial permeability transition Circulation 2005 (in press)
62. I.N. Mungrue, R. Gros, X. You, A. Pirani, A. Azad, and T. Csont Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death J. Clin. Invest. 109 2002 735 743
63. M.R. Duranski, J.J. Greer, A. Dejam, J. Sathya, N. Hogg, and W. Langston Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver J. Clin. Invest. 115 2005 1232 1240
64. T.M. Millar, C.R. Stevens, N. Benjamin, R. Eisenthal, R. Harrison, and D.R. Blake Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions FEBS Lett. 427 1998 225 228
65. D.R. Green, and J.C. Reed Mitochondria and apoptosis Science 281 1998 1309 1312
66. G. Kroemer, and J.C. Reed Mitochondrial control of cell death Nat. Med. 6 2000 513 519
67. S. Shiva, J.-Y. Oh, A.L. Landar, E. Ulasova, A. Venkatraman, and S.M. Bailey Nitroxia: the pathological consequence of dysfunction in the nitric oxide-cytochrome c oxidase signaling pathway Free Radic. Biol. Med. 38 2005 297 306
68. E. Nisoli, S. Falcone, C. Tonello, V. Cozzi, L. Palomba, and M. Fiorani Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals Proc. Natl. Acad. Sci. USA 101 2004 16507 16512
69. G. Wang, D.A. Liem, T.M. Vondriska, H.M. Honda, P. Korge, and D.M. Pantaleon Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition Am. J. Physiol. Heart Circ. Physiol. 288 2005 H1290 H1295
70. V. Borutaite, and G.C. Brown Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide Biochem. J. 315 1996 295 299
71. S. Moncada, and J.D. Erusalimsky Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell Biol. 3 2002 214 220
72. S. Shiva, P.S. Brookes, R.P. Patel, P.G. Anderson, and V.M. Darley-Usmar Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase Proc. Natl. Acad. Sci. USA 98 2001 7212 7217
73. A. Giuffre, P. Sarti, E. D'Itri, G. Buse, T. Soulimane, and M. Brunori On the mechanism of inhibition of cytochrome c oxidase by nitric oxide J. Biol. Chem. 271 1996 33404 33408
74. H. Ardehali, Z. Chen, Y. Ko, R. Mejia-Alvarez, and E. Marban Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K+ channel activity Proc. Natl. Acad. Sci. USA 101 2004 11880 11885
75. N. Sasaki, T. Sato, A. Ohler, B. O'Rourke, and E. Marban Activation of mitochondrial ATP-dependent potassium channels by nitric oxide Circulation 101 2000 439 445
76. Z. Xu, X. Ji, and P.G. Boysen Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK Am. J. Physiol. Heart Circ. Physiol. 286 2004 H1433 H1440
77. O. Oldenburg, Q. Qin, T. Krieg, X.-M. Yang, S. Philipp, and S.D. Critz Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection Am. J. Physiol. Heart Circ. Physiol. 286 2004 H468 H476
78. B. O'Rourke Evidence for mitochondrial K+ channels and their role in cardioprotection Circ. Res. 94 2004 420 432
79. K.H. Lim, S.A. Javadov, M. Das, S.J. Clarke, M.S. Suleiman, and A.P. Halestrap The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration J. Physiol. 545 2002 961 974
80. M. Das, J.E. Parker, and A.P. Halestrap Matrix volume measurements challenge the existence of diazoxide/glibencamide-sensitive KATP channels in rat mitochondria J. Physiol. 547 2003 893 902
81. F. Di Lisa, R. Menabo, M. Canton, M. Barile, and P. Bernardi Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart J. Biol. Chem. 276 2001 2571 2575
82. V. Petronilli, D. Penzo, L. Scorrano, P. Bernardi, and F. Di Lisa The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ J. Biol. Chem. 276 2001 12030 12034
83. A.P. Halestrap The mitochondrial permeability transition pore in reperfusion injury and cardioprotection Cardiovasc. J. S. Afr. 15 2004 S5
84. M. West, G. Rokosh, D. Clark, S. Liu, Y. Guo, and R. Bolli Nitric oxide prevents mitochondrial permeability transition during ischemia-reperfusion: implications for the cardioprotective effects of late preconditioning Circulation 110 2004 III236
85. R.D. Rakhit, M.H. Mojet, M.S. Marber, and M.R. Duchen Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes Circulation 103 2001 2617 2623
86. P.S. Brookes, E.P. Salinas, K. Darley-Usmar, J.P. Eiserich, B.A. Freeman, and V.M. Darley-Usmar Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release J. Biol. Chem. 275 2000 20474 20479